Global Bioanalysis Summit

Meet the expert advisors and Keynote Speakers

Dr. David Dongliang Ge

CEO and President of Apostle

Dr. David Dongliang Ge is CEO and President of Apostle. Apostle Inc is a biotechnology company in Sunnyvale, CA focusing on novel bioinformatics-enabled nanotechnologies for cancer early detection. Previously, he was President of BioSciKin Co. and Simcere Diagnostics Co., two global biotechnology companies headquartered in Nanjing, China focusing on the licensing and sales of diagnostic technologies.

Read more >

Dr. Niren Murthy

University of California at Berkeley, USA

Dr. Niren Murthy is a professor in the Department of Bioengineering at the University of California at Berkeley. Dr. Murthy received his Ph.D. from the University of Washington in Seattle in Bioengineering in 2001, and then did Postdoctoral research at U.C. Berkeley in Chemistry from 2001-2003.

Read more >

Reem Mahrat

Co-founder and VP Calico Bio labs Inc., USA

Calico Biolabs's VP of Operations and Secretary since 2013. Research and Development Manager: Co-developed a number of methodologies and products including novel recombinant monoclonal chicken anti-rabbit and chicken anti-mouse antibodies.

Read more >

Dr. Jennifer Mitcham

Drug Development,Catalent Pharma Solutions, USA

Dr. Jennifer Mitcham is working in the field of Drug Development at Catalent Pharma Solutions in USA

Read more >

Global Bioanalysis Summit 2017 will be held at San Diego, USA on 06 November 2017 with the theme “Discussing current trends and future scope in bioanalysis”. The conference is organized by Clyto Access which aims to bring together outstanding academic scientists, researchers and research scholars to exchange and contribute their experiences and research results on all facets of Bioanalysis. You will meet with the experts from all over the world who are working on Bioanalysis of biological samples, drugs and other metabolites of great interest. The summit is committed to providing a challenging and thought-provoking experience through engaging you in the professional theme.

Points to discuss

☛ various bioanalytical techniques
☛ metabolomics analysis, chemiluminescence sensor
☛ photoelectrochemical biosensor
☛ liquid extraction surface analysis, mass spectrometry imaging
☛ modern challenges of Bioanalysts
☛ role of bioanalysis in novel drug delivery systems

bioanalysis@clytoaccess.com

Related Topics

Biomarker assays, Metabolomics, chemiluminescence sensor, drug delivery , mass spectrometry imaging, photoelectrochemical biosensor, Small molecule bioanalysis, Large molecule bioanalysis, Environmental analysis, Food quality analysis, Forensic Bioanalysis, Drug and metabolite assays, Cell-based bioassays, Radioimmunoassays, Pharmacogenomics assays, Electrophoresis, NMR, Chromatography and separation science, Hyphenated techniques, Drug discovery, Biosensors for food safety, Microscopy, Raman Spectroscopy, Bioanalytical method validation, Trending in bioanalysis.
Abstract submission deadline (1st round)
25 October 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
26 May 2017

AGENDA

☛ Novel Approaches to Analytical and Bioanalytical Methods
☛ Advances in Mass Spectrometry
☛ Bioanalytical Methodology
☛ Recent Applications of Analytical and Bioanalytical Methods
☛ Issues and safety Challenges in Bioanalysis
☛ In vivo and in vitro applications of magnetic resonance
☛ Small Molecules, Peptides and Small Molecule Biomarkers
☛ Method development challenges in bioanalysis
☛ Novel Drug Delivery Systems and Its Major Challenges
☛ Vaccine Design and Delivery Technology
☛ Peptide and Protein Drug Delivery
☛ Drug Delivery Equipments and Machinery
☛ Nanoparticle-based drug delivery system
☛ Computer Aided Drug Design
☛ Drug Discovery Innovation and Strategies, Enabling Technologies
☛ Different approach for the analysis of food contaminants
☛ Advanced Process Control for Food Analytical (Testing)
☛ Small Molecule Drug Discovery & Bioanalysis
☛ Biosimilars Bioanalysis: Challenges and Solutions
☛ Bioanalytical Strategy for Understanding Pharmacokinetics, Pharmacodynamics and Immunogenicity
☛ Micro and Nano Drug Delivery Systems
☛ Bioanalysis for Cancer Diagnosis
☛ Controversial Topics in Bioanalysis
☛ Bioanalytical Issues with Biomarkers
☛ Biomarkers in Drug Discovery and Development
☛ Innovations in Biomarkers Research, Assay Development
☛ Bioanalysis of Antibody Drugs
☛ Market Trend and Business Development of Drug Delivery Systems

What is Bioanalysis 2017?

Global Bioanalysis Summit 2017 is a two- day conference designed to encourage researchers in the field of bioanalysis and to explore the new analytical platforms to challenge future, providing an opportunity to learn about advances in technology, new approaches to bioassays and bioanalytical techniques development. We request all the professionals and industrialists working in the field of bioanalysis and bioanalytical techniques development to come together, to share their best practices for analysis of biological samples and to discuss the novel methods for analyzing the biological samples, to participate and share experiences with the global researchers.

Who to attend Bioanalysis 2017 ?

• Chief Scientific officer, R & D President
• Chief scientists
• Principal scientists/investigator
• Professor- drug metabolism
• Professor- pharmacology and toxicology
• Head of bioanalytical science
• R & D head
• R & D analysts
• Analytical chemists
• LCMS technologists
• Mass spectrometry specialists
• NMR technologists
• Food technologists
• Prof- food science Lab head
• Senior vice president & managing director
• Regulatory affairs director
• Executive director
• Head of clinical biomarkers & diagnostics
• Business development manager
• Senior director
• Head of clinical pharmacology
• Head of clinical research
• Head of Drug Delivery & DMPK

Why to attend Bioanalysis 2017 ?

Bioanalysis 2017 provides the bioanalyst with a forum for sharing the original research on: Analyte extraction and sample preparation, Biomarker assays, Chromatography and separation sciences, Diagnostic assays and test kits, Drug and metabolite assays, Innovative bioanalytical methods, Mass spectrometry and other key detection methods, New instrumentation and equipment, Pharmacogenomics assays to the other participants.

MARKET ANALYSIS


The biologics market is estimated to be approximately $190-200 billion by 2015 with a growth rate of 9.9% from 2010. Increased share of a large molecule in Pharma R&D pipeline has increased the demand for more Bioanalytical testing. In this scenario, Pharma companies are increasingly adopting outsourcing (from 26% of Bioanalytical spending in 2011-2012 to 36% in 2012-2013) as a strategy to contain cost, reduce the time and access expertise. The growth in small molecule NCEs (New Chemical Entity) has been less than 1% per annum in contrast to that of large molecule NBE (New Biological Entity) which is about 25% from 2000 to 2010. Furthermore, the sale of the small molecules is growing at a CAGR of 3.9% and that of large molecules at a CAGR of 10.1% from 2009 to 2015. The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. The global pharmaceutical market is expected to surpass US$400 bn by 2018. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

CONFERENCE HIGHLIGHTS


The open panel discussion intends to have a solemn discussion involving current challenges in the area of bioanalysis in which all attendees can interact with the panel followed by a Q/A session.
The attendees can interact with each other and exchange ideas that can be of great help to someone conducting analogous research.
Keynote speakers and speakers would share their expertise and their current research work. The students (Ph.D. and Post Doc. Fellows) can present their posters.
Industry professionals and academic professionals delivering a workshop on various methods and techniques, with interactive Q&A session.

Organizing Committee

Our Speakers

Programs Programs Detail Time
1

SPOT REGISTRATIONS

08:00 AM
2

INAUGURATION OF GLOBAL BIOANALYSIS SUMMIT 2017

09:00 AM
3

KEYNOTE SESSIONS #1

09:30 AM
4

REFRESHMENTS BREAK

10:30 AM
5

KEYNOTE SESSIONS #2

11:00 AM
6

REFRESHMENTS - LUNCH BREAK

12:30 PM
7

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

01:30 PM
8

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

03:30 PM
9

DAY #1 - CLOSURE

06:00 PM

venue

San Diego, USA

address